Richard Frank, MD, PhD, FFPM (RCP)
Chief Medical Officer
 

Dr Frank brings 35 years’ global success in a) regulatory labelling of, b) public and private coverage and payment for, and c) clinical adoption of, therapeutic and diagnostic drugs and devices including AI.  Long experience has facilitated opinion leadership in clinical evidentiary standards and related matters of government policy.  His interests include addressing product-, market-, or delivery system-specific inefficiencies and issues which burden payers and delay or skew patients’ access to the benefits of innovation.  Dr Frank is devoted to the development of and advocacy for policy, regulations, standards, and best practices regarding healthcare AI.